Your shopping cart is currently empty

PI3Kδ-IN-27 is a PI3Kδ inhibitor with an IC50 of 355.3 nM. It exhibits activity against SARS-CoV-2 and can be utilized in infection-related studies, such as those concerning COVID-19.
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 10-14 weeks |
| Description | PI3Kδ-IN-27 is a PI3Kδ inhibitor with an IC50 of 355.3 nM. It exhibits activity against SARS-CoV-2 and can be utilized in infection-related studies, such as those concerning COVID-19. |
| Targets&IC50 | PI3Kδ:355.3 nM |
| In vitro | PI3Kδ-IN-27 exhibits inhibitory effects on SARS-CoV-2 Beta, Delta, and Omicron strains in Vero E6 cells, with IC50 values of 5.60 μM, 5.43 μM, and 4.97 μM, respectively, and selectivity indices (SI) of 24.89, 25.66, and 28.04. In Vero-E6 and A549 cells, its CC50 values are 139.36 μM and 125.79 μM, respectively. |
| In vivo | PI3Kδ-IN-27 (15 mg/kg, administered intraperitoneally, once daily for 4 days) significantly inhibits viral replication in lung tissue within a SARS-CoV-2 infected golden hamster model. |
| Molecular Weight | 380.45 |
| Formula | C21H24N4O3 |
| Cas No. | 3097471-25-2 |
| Smiles | OCC=1C=CC=C(C1)C2=NC3=C(ON=C3C4CCCC4)C(=N2)N5CCOCC5 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.